alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 31(ii) **Rule 13a-14(a)/15d-14(a)  Certification of Mr. Reuben Gamoran 
I, Reuben Gamoran, certify that:
1.
I have reviewed this Annual Report on Form 10-K of Wm. Wrigley Jr. Company;
2.
Based on my knowledge, this Annual Report does not contain any untrue statement or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Annual Report;
3.
Based on my knowledge, the financial statements, and other financial information included in this Annual Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this Annual Report;
4.
The Company's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 and 15d-15) for the Company, and we have:   
(a)
designed such disclosure controls and procedures to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Annual Report is being prepared; 
(b)
evaluated the effectiveness of the Company's disclosure controls and procedures as of a date within 90 days prior to the filing date of this Annual Report (the "Evaluation Date"); and 
(c)
presented in this Annual Report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date.
5.
The Company's other certifying officer and I have disclosed, based on our most recent evaluation, to the Company's auditors and the audit committee of the Company's Board of Directors (or persons performing the equivalent function): 
(a)
all significant deficiencies in the design or operation of internal controls which could adversely affect the Company's ability to record, process, summarize and report financial data and have identified for the Company's auditors any material weaknesses in internal controls; and 
(b)
fraud, whether or not material, that involves management or other employees who have a significant role in the Company's control; and
6.
The Company's other certifying officer and I have indicated in this Annual Report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.  
Date:  February 9, 2004 
/s/ REUBEN GAMORAN                            
Reuben Gamoran****
<PAGE>   1



                        Med/Waste Inc. and Subsidiaries

             Exhibit 11 - Computation of Earnings (Loss) Per Share

                                  (Unaudited)





<TABLE>
<CAPTION>
                                                             Three Months Ended September 30, 1996
                                                             -------------------------------------
                                                                1996                        1995
                                                             ---------                   ---------
 <S>                                                         <C>                     <C>
 Net income (loss)                                           $   (49,310)            $      12,287
                                                             ===========             =============
                                                                            
 Weighted average shares outstanding                           2,067,147                 1,874,017
                                                             ===========             =============

 Net earnings (loss) per share                               $      (.02)            $         .01
                                                             ===========             =============





                                                               Nine Months Ended September 30, 1996
                                                               ------------------------------------

                                                                 1996                        1995


 Net income (loss)                                           $   135,075             $    (180,901)
                                                             ===========             =============
 Weighted average shares outstanding                           1,962,723                 1,876,219
                                                             ===========             =============
 Net earnings (loss) per share                               $       .07             $        (.10)
                                                             ===========             =============
</TABLE>




                                       14
CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002



I, Donald M. Boone, certify that:

1.

I have reviewed this amended quarterly report on Form 10-Q/A of Jewett Cameron Trading Company Ltd..;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

c)

Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and

5.

The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):

a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.

Date:

September 15, 2006

By:

Donald M. Boone

Donald M. Boone,

President/CEO/Director

|
|
IN THE COURT OF CRIMINAL APPEALS

OF TEXAS

NOS. PD-0601-20; PD-0602-20; PD-0603-20

ROBERTO DELPILAR JASSO, Appellant

V.

THE STATE OF TEXAS

ON APPELLANT’S PETITION FOR DISCRETIONARY REVIEW

FROM THE FIFTH COURT OF APPEALS

DALLAS COUNTY

Per curiam.

O P I N I O N

Appellant was convicted of three counts of aggravated robbery and sentenced to 99

years in prison. After the trial court denied his motions for new trial, he filed amended

motions for new trial. The judge denied those motions without a hearing. The Court of

Appeals affirmed, holding that, once the trial court denied Appellant’s initial motions for
JASSO - 2

new trial, Appellant “could no longer file” amended motions. Jasso v. State, No. 05-19-

00117-CR, 2020 Tex. App. LEXIS 4278 (Tex. App.—Dallas June 9, 2020). The appellate

court relied on Rubio v. State, 596 S.W.3d 410 (Tex. App.—Dallas 2020).

Appellant has filed a petition for discretionaryreview challenging the court’s analysis.

We recently reversed the Rubio opinion. Rubio v. State, No. PD-0234-20, 2022 Tex. Crim.

App. LEXIS 32 (Tex. Crim. App. January 22, 2022). In our opinion, we held that “Texas

Rule of Appellate Procedure 21.4(b) affords the trial court the discretion to grant leave of

court to allow a defendant to file an amended motion for new trial prior to the expiration of

the 30-day time period provided for in Rule 21.4(a), and that the court may do so regardless

of whether it has overruled a previous motion for new trial.”

The Court of Appeals did not have the benefit of our opinion in Rubio. Accordingly,

we grant Appellant’s petition for discretionary review, vacate the judgment of the Court of

Appeals, and remand this case to the Court of Appeals in light of our opinion in Rubio.

DATE DELIVERED: March 9, 2022

DO NOT PUBLISH
IN THE DISTRICT COURT OF APPEAL OF THE STATE O F FLORIDA FIFTH DISTRICT NOT FINAL UNTIL TIME E XPIRES TO FILE MOTION FOR REHEARING AND DISPOSITION THEREOF IF FILED BORDERLESS CAPITAL LLC AND DAVID GARCIA ,
Case No. 5D 22

- 1707 LT Case No. 2021

- CA

- 985

- A Appellant s,

v. NEKTRA, S.A. D/B/A COINFABRIK, RAND LABS, L LC, RAND LABS, I NC., AND P ABLO YAB O,

Appellee s. ________________________________/ Decision filed J uly 3, 2023 Non f inal A ppeal f rom t he Circ uit Court for Lake County , Da n R. Mosley , Judge. George G

. Mahfood and Ryan K. Todd, o f N elson Mullins Riley & Scarborough, LLP , Miami, for Appellants. Patricia Acosta, Brett Alan Barfield, and Alexandra Goodstone, of PAG Law PLLC, Miami, for Appellee, Nektra, S .A., d/b/a Coinfabrik

. No Appearance for Appellees , R and Labs, L LC, Rand L abs Inc

. , an d Pablo Y abo

. PER CURIAM. AFFIRMED. EDWARDS, C.J., J AY an d MACIVER , JJ. , concur.
IN THE SUPREME COURT OF THE STATE OF MONTANA

DA 21-0016

_________________

STATE OF MONTANA,

 Plaintiff and Appellee,

 v.

DONALD GARZA,

 Defendant and Appellant.

O R D E R

_________________

Pursuant to the Internal Operating Rules of this Court, this cause is classified for 

submission on briefs to a five-justice panel of this Court. 

The Clerk is directed to provide a copy hereof to all counsel of record and to the 

Honorable Peter B. Ohman, District Judge.

For the Court,

Electronically signed by:

Mike McGrath

Chief Justice, Montana Supreme Court

March 1 2023

03/01/2023

Case Number: DA 21-0016
exv10w37







EXHIBIT 10.37




Director Compensation Summary




(effective as of September 10, 2008)



     Employee directors receive no additional compensation other than their normal salary for serving on
the Board or its committees. Non-employee directors receive $45,000 annually. In addition, the
Chairman of the Audit Committee receives a $25,000 annual retainer. The Chairmen of the
Compensation and the Nominating and Corporate Governance Committees each receive an additional
$20,000 annual retainer. Each Audit Committee member (other than the Chairman of the Committee)
receives and additional $12,500 annual retainer. Each member of the Compensation and Nominating and
Corporate Governance Committees (other than the Chairmen of those Committees) receives an
additional 10,000 annual retainer. Outside directors also receive an initial grant, upon first
election or appointment, and an annual grant of shares of restricted stock equal to $125,000, which
valuation is based on the price of Newpark stock on the date of the grant (appointment, election or
re-election).
EXHIBIT 31.1
**RULE 13a-14(a)/15d-14(a) CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER**
     I, Donald E. Graham, Chief Executive Officer (principal executive officer)of The Washington Post Company (the “Registrant”), certify that:
          1. I have reviewed this annual report on Form 10-K of the Registrant;
          2. Based on my knowledge, this report does not contain any untruestatement of a material fact or omit to state a material fact necessary tomake the statements made, in light of the circumstances under which suchstatements were made, not misleading with respect to the period covered bythis report;
          3. Based on my knowledge, the financial statements and other financialinformation included in this report, fairly present in all material respectsthe financial condition, results of operations and cash flows of theRegistrant as of, and for, the periods presented in this report;
          4. The Registrant’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (as definedin Exchange Act Rules 13a-15(e) and 15d-15(e))for the Registrant and have:
          (a) Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, toensure that material information relating to the Registrant, including itsconsolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is beingprepared;
          (b) Evaluated the effectiveness of the Registrant’s disclosure controlsand procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of theperiod covered by this report based upon such evaluation; and
          (c) Disclosed in this report any change in the Registrant’s internalcontrol over financial reporting that occurred during the Registrant’s fourthfiscal quarter that has materially affected, or is reasonable likely tomaterially affect, the Registrant’s internal control over financialreporting;
          5. The Registrant’s other certifying officer and I have disclosed,based on our most recent evaluation of internal control over financialreporting, to the Registrant’s auditors and the audit committee ofRegistrant’s board of directors (or persons performing the equivalentfunctions):
          (a) All significant deficiencies and material weaknesses in the designor operation of internal control over financial reporting which arereasonably likely to adversely affect the Registrant’s ability to record,process, summarize and report financial information; and
          (b) Any fraud, whether or not material, that involves management orother employees who have a significant role in the Registrant’s internalcontrol over financial reporting.    Date: March 9, 2004 By/s/ Donald E. Graham          Donald E. Graham,
**REPORT OF INDEPENDENT CERTIFIED PUBLIC  ACCOUNTANTS**

  To the Shareholders and Board of Trustees  Saturna Investment Trust  We have audited the accompanying statement of assets and liabilities of the  Sextant Short-Term Bond Fund, Sextant Bond Income Fund, Sextant Growth Fund  and Sextant International Fund, each a series of the Saturna Investment Trust,  including the schedules of investments as of November 30, 2003, and therelated  statements of operations for the year then ended, and the changes in netassets  for each of the two years then ended, and the financial highlights for each  of the five years then ended. These financial statements and financialhighlights  are the responsibility of the Trust’s management. Our responsibility is  to express an opinion on these financial statements and financial highlights  based on our audits.  We conducted our audits in accordance with auditing standards generallyaccepted  in the United States of America. Those standards require that we plan andperform the audit to obtain reasonable  assurance about whether the financial statements and financial highlights are  free of material misstatement. An audit includes examining, on a test basis,  evidence supporting the amounts and disclosures in the financial statements.  Our procedures included confirmation of securities owned as of November 30,  2003, by correspondence with the custodian and broker. Our audit also includesassessing  the accounting principles used and significant estimates made by management,  as well as evaluating the overall financial statement presentation. We believe  that our audits provide a reasonable basis for our opinion.   In our opinion the financial statements and financial highlights referred to  above present fairly, in all material respects, the financial position ofSextant  Short-Term Bond Fund, Sextant Bond Income Fund, Sextant Growth Fund, andSextant  International Fund, as of November 30, 2003, the results of their operations  for the year then ended, and the changes in their net assets for each of the  two years then ended and their financial highlights for each of the five years  in the period then ended, in conformity with accounting principles generallyaccepted in the United States of America.

/s/signature

**TAIT, WELLER&  BAKER**

Philadelphia, Pennsylvania  January 8, 2004
**CERTIFICATION      PURSUANT TO**

**18      U.S.C. §1350,**

**AS      ADOPTED PURSUANT TO**

**SECTION      906 OF THE SARBANES-OXLEY ACT OF 2002**

|  | (1) | the                Quarterly Report on Form 10-QSB of StatSure Diagnostic Systems, Inc.                for                the quarter ended June 30, 2007 as filed with the Securities and                Exchange                Commission on the date hereof, fully complies with the requirements                of                Section 13(a) or 15(d), as applicable, of the Securities Exchange                Act of                1934; and |
|--|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | (2) | the                information contained in the such Quarterly Report on Form 10-QSB                of                StatSure Diagnostic Systems, Inc. for the quarter ended June 30,                2007                fairly presents, in all material respects, the financial condition                and                results of operations of StatSure Diagnostic Systems,                Inc. |
|--|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | /s/                Steve M. Peltzman        |
|--------|---------------------------------------------|
|   | Steve                M. Peltzman            |
|   | Chief                Executive Officer      |
|   | (principal                executive officer |
|   | and                duly authorized officer) |

----
No. 828.

#### Mitchell *v.*Hunter, Warden.

June 3, 1946.

Petitioner *pro se.*

*Solicitor General McGrath, Robert S. Erdahl*and *Andrew F. Oehmann*for respondent.

Petition for writ of certiorari to the Circuit Court of Appeals for the Tenth Circuit denied.
##### 



SECTION 1350 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND
THE CHIEF FINANCIAL OFFICER
  (1)
    
    The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and(2)
    
    The information contained in the Report fairly presents, in all material aspects,
the financial condition and results of operations of the Company.
 Date: February 27, 2008
    
    /s/ Donald E. GrahamDonald E. Graham,Chief Executive OfficerDate: February 27, 2008
    
    /s/ John B. Morse, Jr.John B. Morse, Jr.Vice PresidentFinance
[Federal Register Volume 82, Number 155 (Monday, August 14, 2017)]
[Notices]
[Page 37884]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17041]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health and 
Human Development; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Initial Review Group Pediatrics Subcommittee.
    Date: October 12, 2017.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Rita Anand, Ph.D., Scientific Review Officer 
Division of Scientific Review National Institute of Child Health and 
Human Development, NIH, 6710B Rockledge Drive, MSC 7002, Bethesda, 
MD 20892, (301) 496-1487, <a href="/cdn-cgi/l/email-protection#99f8f7f8f7fdebd9f4f8f0f5b7f7f0f1b7fef6ef"><span class="__cf_email__" data-cfemail="4e2f202f202a3c0e232f27226020272660292138">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: August 8, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-17041 Filed 8-11-17; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>